*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Margaret E. KosalMargaret Kosal, associate professor in the Sam Nunn School of International Affairs was cited in Genetic Engineering & Biotechnology News.
Excerpt:
“Sometimes a seemingly innocuous project can take on more malevolent overtones,” Dr. Kosal explains. “For example, a biotech company in southeast Asia decided to engineer a more potent form of the botulinum toxin. From a commercial point of view this makes sense, as less of the product would be needed to have the same effect in cosmetic and medical treatments. Unfortunately, from a biosecurity standpoint, this means the potency of a potential biological weapon increased.”
Read the complete article here.
